Company / Current Liabilities per Share
TherapeuticsMD, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.45
FY2024
5-year range
$0.22 / $5.45
FY2020-FY2024
Trend
-37.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2017 to $5.45 in FY2022.
Based on SEC 10-K filings.
0.45 in FY2024 with a 5-year CAGR of +15.2%.
Improved from $5.45 to $0.45 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -19.0%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 37.9% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.45 | -37.9% |
| FY2023 | $0.72 | -86.8% |
| FY2022 | $5.45 | +545.7% |
| FY2021 | $0.84 | +286.2% |
| FY2020 | $0.22 | -0.9% |
| FY2019 | $0.22 | +16.1% |
| FY2018 | $0.19 | +180.2% |
| FY2017 | $0.07 | -19.6% |
| FY2016 | $0.08 | +14.5% |
| FY2015 | $0.07 | -0.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026